Evotec AG Shares Outstanding 2006-2020 | EVTCY

Evotec AG shares outstanding history from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Evotec AG shares outstanding for the quarter ending September 30, 2020 were 0.076B, a 0.82% increase year-over-year.
  • Evotec AG 2019 shares outstanding were 0.075B, a 1.52% increase from 2018.
  • Evotec AG 2018 shares outstanding were 0.074B, a 1.7% increase from 2017.
  • Evotec AG 2017 shares outstanding were 0.073B, a 9.43% increase from 2016.
Evotec AG Annual Shares Outstanding
(Millions of Shares)
2019 75
2018 74
2017 73
2016 66
2015 66
2014 66
2013 61
2012 59
2011 56
2010 50
2009
2008 95
2007 72
2006
2005
Evotec AG Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 76
2020-06-30 76
2020-03-31 75
2019-12-31 75
2019-09-30 75
2019-06-30 75
2019-03-31 75
2018-12-31 74
2018-09-30 74
2018-06-30 74
2018-03-31 74
2017-12-31 73
2017-09-30 73
2017-06-30 73
2017-03-31 70
2016-12-31 66
2016-09-30 66
2016-06-30 66
2016-03-31 66
2015-12-31 66
2015-09-30 66
2015-06-30 66
2015-03-31 66
2014-12-31 51
2014-09-30 66
2014-06-30 66
2014-03-31 66
2013-12-31 61
2013-09-30 59
2013-06-30 59
2013-03-31 59
2012-12-31 59
2012-09-30 59
2012-06-30 61
2012-03-31 50
2011-12-31 61
2011-09-30 58
2011-06-30 61
2011-03-31 57
2010-12-31 56
2010-09-30 54
2010-06-30 54
2010-03-31 65
2009-12-31
2009-09-30 53
2009-06-30 53
2009-03-31 53
2008-12-31 99
2008-09-30 59
2008-06-30 47
2008-03-31 74
2007-12-31
2007-09-30
2007-06-30
2007-03-31 68
2006-12-31
2006-09-30
2006-06-30
2006-03-31
2005-12-31
2005-09-30
2005-06-30
2005-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.684B $0.500B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.264B 42.12
Takeda Pharmaceutical (TAK) Japan $54.984B 10.26
Astellas Pharma (ALPMY) Japan $29.696B 18.55
Merck (MKGAF) Germany $23.264B 0.00
Eisai (ESALY) Japan $21.993B 19.16
UCB SA (UCBJF) Belgium $20.900B 0.00
Catalent (CTLT) United States $19.736B 59.03
Grifols, S.A (GRFS) Spain $13.600B 15.57
Neurocrine Biosciences (NBIX) United States $10.163B 79.99
Jazz Pharmaceuticals (JAZZ) Ireland $9.304B 15.03
Ionis Pharmaceuticals (IONS) United States $8.533B 83.60
Arrowhead Pharmaceuticals (ARWR) United States $8.441B 0.00
United Therapeutics (UTHR) United States $7.626B 16.24
IPSEN SA ADR (IPSEY) France $7.218B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Sage Therapeutics (SAGE) United States $4.661B 0.00
PTC Therapeutics (PTCT) United States $4.478B 0.00
ChemoCentryx (CCXI) United States $4.213B 0.00
Hypermarcas (HYPMY) Brazil $4.212B 16.63
FibroGen (FGEN) United States $4.006B 0.00
Cronos Group (CRON) Canada $3.946B 0.00
Corcept Therapeutics (CORT) United States $3.340B 32.30
Pacira BioSciences (PCRX) United States $3.208B 69.67
Nektar Therapeutics (NKTR) United States $3.089B 0.00
Revolution Medicines (RVMD) United States $2.852B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.851B 14.56
Xencor (XNCR) United States $2.842B 0.00
Tilray (TLRY) Canada $2.683B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.758B 15.04
USANA Health Sciences (USNA) United States $1.733B 15.25
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.725B 0.00
Translate Bio (TBIO) United States $1.708B 0.00
Heron Therapeutics (HRTX) United States $1.631B 0.00
Endo (ENDP) Ireland $1.626B 2.47
BioCryst Pharmaceuticals (BCRX) United States $1.601B 0.00
ImmunoGen (IMGN) United States $1.546B 0.00
Ocular Therapeutix (OCUL) United States $1.523B 0.00
Trillium Therapeutics (TRIL) Canada $1.494B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.448B 10.06
Indivior (INVVY) United States $1.309B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.182B 0.00
Karyopharm Therapeutics (KPTI) United States $1.110B 0.00
ORGANOGENESIS (ORGO) United States $1.023B 0.00
Zogenix (ZGNX) United States $1.017B 0.00
Radius Health (RDUS) United States $1.008B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.963B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Collegium Pharmaceutical (COLL) United States $0.832B 49.10
Aclaris Therapeutics (ACRS) United States $0.808B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.770B 0.00
VAXART, INC (VXRT) United States $0.756B 0.00
Aerie Pharmaceuticals (AERI) United States $0.706B 0.00
Esperion Therapeutics (ESPR) United States $0.700B 0.00
Acutus Medical (AFIB) United States $0.658B 0.00
Chinook Therapeutics (KDNY) United States $0.640B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.637B 0.00
Ardelyx (ARDX) United States $0.616B 0.00
Harpoon Therapeutics (HARP) United States $0.613B 0.00
Flexion Therapeutics (FLXN) United States $0.590B 0.00
Molecular Templates (MTEM) United States $0.589B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.581B 0.00
Siga Technologies (SIGA) United States $0.557B 15.63
Crinetics Pharmaceuticals (CRNX) United States $0.497B 0.00
Sundial Growers (SNDL) Canada $0.488B 0.00
PROFOUND MEDICL (PROF) Canada $0.465B 0.00
Akebia Therapeutics (AKBA) United States $0.454B 0.00
Altimmune (ALT) United States $0.449B 0.00
Summit Therapeutics (SMMT) United States $0.431B 0.00
CASI Pharmaceuticals (CASI) United States $0.429B 0.00
TherapeuticsMD (TXMD) United States $0.426B 0.00
DURECT (DRRX) United States $0.423B 0.00
Rafael Holdings (RFL) United States $0.396B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.394B 0.00
Jounce Therapeutics (JNCE) United States $0.384B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.371B 9.68
Innate Pharma SA (IPHYF) France $0.371B 0.00
MEI Pharma (MEIP) United States $0.347B 0.00
Concert Pharmaceuticals (CNCE) United States $0.334B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.329B 0.00
Alpine Immune Sciences (ALPN) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.306B 19.73
KalVista Pharmaceuticals (KALV) United States $0.305B 0.00
Menlo Therapeutics (VYNE) United States $0.299B 0.00
Redhill Biopharma (RDHL) Israel $0.291B 0.00
Lannett Co Inc (LCI) United States $0.281B 7.41
Xeris Pharmaceuticals (XERS) United States $0.275B 0.00
Jaguar Animal Health (JAGX) United States $0.263B 0.00
Otonomy (OTIC) United States $0.250B 0.00
IMV INC (IMV) Canada $0.248B 0.00
CTI BioPharma (CTIC) United States $0.239B 0.00
Oncternal Therapeutics (ONCT) United States $0.226B 0.00
Infinity Pharmaceuticals (INFI) United States $0.223B 0.00
Calithera Biosciences (CALA) United States $0.219B 0.00
OptiNose (OPTN) United States $0.215B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.213B 0.00
IsoRay (ISR) United States $0.210B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.205B 0.00
Novan (NOVN) United States $0.185B 0.00
Aquestive Therapeutics (AQST) United States $0.183B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.176B 0.00
Taiwan Liposome (TLC) Taiwan $0.172B 0.00
Onconova Therapeutics (ONTX) United States $0.161B 0.00
Heat Biologics (HTBX) United States $0.157B 0.00
Champions Oncology (CSBR) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.148B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.145B 0.00
ProPhase Labs (PRPH) United States $0.145B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Lipocine (LPCN) United States $0.116B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.108B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.105B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.099B 0.00
ElectroCore (ECOR) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Natural Alternatives (NAII) United States $0.083B 161.13
Galmed Pharmaceuticals (GLMD) Israel $0.079B 0.00
Nutriband (NTRB) United States $0.077B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.072B 0.00
Biomerica (BMRA) United States $0.072B 0.00
Recro Pharma (REPH) United States $0.072B 0.00
AgeX Therapeutics (AGE) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.069B 0.00
India Globalization Capital (IGC) United States $0.066B 0.00
Iterum Therapeutics (ITRM) Ireland $0.064B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Vical (BBI) United States $0.060B 0.00
Addex Therapeutics (ADXN) Switzerland $0.058B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 24.58
Regulus Therapeutics (RGLS) United States $0.045B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.043B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 5.74
Neos Therapeutics (NEOS) United States $0.037B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.030B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
Flex Pharma (SLRX) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
KemPharm (KMPH) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 31.90
Xenetic Biosciences (XBIO) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00